DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Evista (Raloxifene) - Femur Fracture - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Femur Fracture (16)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Evista (Raloxifene) where reactions include femur fracture. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Evista side effects in

Reported by a consumer/non-health professional from United States on 2012-07-10

Patient:

Reactions: Femur Fracture, Breast Cancer in Situ, Chronic Obstructive Pulmonary Disease, Fall, Breast Cyst, Breast Hyperplasia, Fibula Fracture, Injury, Hypercalciuria, LOW Turnover Osteopathy, Mitral Valve Prolapse, Lung Neoplasm, Breast Mass, Granuloma, Ankle Fracture, Rhinitis Allergic, Bone Neoplasm Malignant, Lung Disorder, Procedural Vomiting, Procedural Nausea, Sleep Apnoea Syndrome, Face Injury

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Evista
    Indication: Bone Disorder
    Start date: 2008-01-01

Fosamax
    Dosage: 70 mg, qw
    Administration route: Oral
    Start date: 2002-01-31
    End date: 2010-01-01

Fosamax
    Administration route: Oral
    Indication: Osteopenia
    Start date: 2000-10-01
    End date: 2009-09-01

Fosamax
    Dosage: 10 mg, unk
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2000-10-01
    End date: 2001-12-17

Other drugs received by patient: Calcium (Unspecified); Vitamin D (Unspecified); MK-9278



Possible Evista side effects in female

Reported by a consumer/non-health professional from United States on 2012-06-25

Patient: female, weighing 55.8 kg (122.7 pounds)

Reactions: Femur Fracture, Contusion, Blood Calcium Increased, Blood Triglycerides Increased, Intentional Drug Misuse, Fall, Abdominal Discomfort, Fatigue, Malaise, Dizziness, Blood Cholesterol Increased, Vomiting, Retching, Nausea, Urinary Tract Infection, Cholelithiasis, HIP Fracture, Heart Rate Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Evista
    Dosage: unk, unknown

Forteo
    Dosage: 20 ug, qd
    Indication: Osteoporosis
    Start date: 2011-04-01
    End date: 2011-04-05

Forteo
    Dosage: 20 ug, qd

Forteo
    Dosage: 20 ug, qd

Forteo
    Dosage: 20 ug, qd
    Start date: 2011-04-11

Forteo
    Dosage: 20 ug, qd

Forteo
    Dosage: 20 ug, qd

Other drugs received by patient: Pseudoephedrine HCL; Calcium W / Vitamin D NOS; Pravachol; Cortisone Acetate; Proair HFA; Excedrin (Migraine); Tylenol (Caplet); Spiriva; Claritin



Possible Evista side effects in 92 year old female

Reported by a physician from United States on 2012-05-11

Patient: 92 year old female

Reactions: Vaginal Prolapse, Vitamin D Deficiency, Joint Instability, Femur Fracture, Flatulence, Chronic Obstructive Pulmonary Disease, Iron Deficiency Anaemia, Carotid Artery Occlusion, Ingrowing Nail, Sinus Congestion, LOW Turnover Osteopathy, White Blood Cell Count Increased, Intervertebral Disc Protrusion, Dysphagia, Pneumonia, Anaemia, Drug Intolerance, Sinus Operation, Inguinal Hernia, Glaucoma, Pain, Myelodysplastic Syndrome, Cystocele, Overdose, Road Traffic Accident, Fibrocystic Breast Disease, Gastrooesophageal Reflux Disease, Blood Iron Increased, Tooth Fracture, Blood Urea Increased, Urinary Tract Infection, Nephrogenic Anaemia, Blood Potassium Increased, Carotid Artery Stenosis, Syncope, Hypothyroidism, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Actonel
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2005-08-13
    End date: 2005-11-01

Actonel
    Administration route: Oral
    Start date: 2006-04-12
    End date: 2006-04-20

Actonel
    Administration route: Oral
    Start date: 2004-09-28
    End date: 2004-11-01

Alendronate Sodium
    Administration route: Oral
    Start date: 2008-08-02
    End date: 2009-03-13

Alendronate Sodium
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2008-06-07
    End date: 2008-08-01

Evista
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2005-10-27

Fosamax
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2001-03-13
    End date: 2004-09-28

Fosamax
    Administration route: Oral
    Start date: 1999-01-01
    End date: 2001-03-13

Fosamax
    Administration route: Oral
    Start date: 2001-03-08

Fosamax
    Administration route: Oral
    Start date: 2005-07-13
    End date: 2010-01-11



Possible Evista side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-02

Patient: female

Reactions: Femur Fracture, Drug Ineffective, Pain in Extremity, Fall, HIP Fracture, Ecchymosis, Oedema Peripheral, Transfusion, Mobility Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Evista

Other drugs received by patient: Prolia; Magnesium; Synthroid; Antihypertensives; Vitamin TAB; Calcium; Analgesics; Fish OIL



Possible Evista side effects in female

Reported by a consumer/non-health professional from United States on 2012-04-17

Patient: female

Reactions: Body Height Decreased, Femur Fracture, Wrist Fracture, Lower Limb Fracture

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Evista

Other drugs received by patient: Lovastatin; Meloxicam; Calcium Carbonate; Lecithin; Gabapentin; Vitamin D; Antacids, Other Combinations



Possible Evista side effects in 65 year old female

Reported by a physician from United States on 2012-04-11

Patient: 65 year old female

Reactions: Weight Decreased, Femur Fracture, Urinary Incontinence, Diverticulitis, Sciatica, Clostridium Difficile Colitis, Pyrexia, Nocturia, Fracture, Iron Deficiency Anaemia, Musculoskeletal Disorder, Tracheitis, Anaemia Postoperative, Pneumonia, Cerumen Impaction, Vulvovaginal Candidiasis, Type V Hyperlipidaemia, Bunion, Bone Pain, Adverse Drug Reaction, Fall, Constipation, Fatigue, Interstitial Lung Disease, Aortic Arteriosclerosis, Intervertebral Disc Degeneration, Injury, Sinusitis, Pharyngitis, Decreased Appetite, Vomiting, Mixed Incontinence, Diarrhoea, Pseudomembranous Colitis, Lung Infiltration, Leukocytosis, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Alendronate Sodium
    Administration route: Oral
    Start date: 2008-03-23
    End date: 2010-01-08

Evista
    Administration route: Oral
    Indication: Osteoporosis

Fosamax
    Administration route: Oral
    End date: 2010-01-08

Fosamax
    Administration route: Oral

Fosamax
    Administration route: Oral
    Indication: Osteopenia
    Start date: 1999-01-01
    End date: 2009-01-01

Fosamax
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 1999-01-01
    End date: 2009-01-01

Fosamax
    Administration route: Oral
    End date: 2010-01-08

Fosamax
    Administration route: Oral

Fosamax Plus D
    Administration route: Oral
    Start date: 2006-10-18
    End date: 2007-09-17

Other drugs received by patient: Omega-3 Marine Triglycerides; Vitamin E; Selective Estrogen Receptor Modulator (Unspecified); Viactiv Soft Calcium Chews; Citracal; Vitamins (Unspecified); Lovaza; Vitamin D (Unspecified)



Possible Evista side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-29

Patient: female

Reactions: HIP Fracture, Femur Fracture, Pain in Extremity, Oedema Peripheral, Ecchymosis, Transfusion, Fall

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Evista

Other drugs received by patient: Calcium Carbonate; Antihypertensives; Synthroid; Vitamin TAB; Fish OIL; Magnesium; Analgesics



Possible Evista side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-23

Patient: female, weighing 55.8 kg (122.7 pounds)

Reactions: Contusion, Femur Fracture, Blood Triglycerides Increased, Blood Calcium Increased, Intentional Drug Misuse, Fall, Abdominal Discomfort, Fatigue, Malaise, Dizziness, Blood Cholesterol Increased, Vomiting, Nausea, Retching, Urinary Tract Infection, HIP Fracture, Heart Rate Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Evista
    Dosage: unk, unknown

Forteo
    Dosage: 20 ug, qd
    Start date: 2011-04-11

Forteo
    Dosage: 20 ug, qd

Forteo
    Dosage: 20 ug, qd

Forteo
    Dosage: 20 ug, qd
    Indication: Osteoporosis
    Start date: 2011-04-01
    End date: 2011-04-05

Forteo
    Dosage: 20 ug, qd

Forteo
    Dosage: 20 ug, qd

Other drugs received by patient: Cortisone Acetate; Calcium W / Vitamin D NOS; Excedrin (Migraine); Tylenol (Caplet); Pseudoephedrine HCL; Claritin; Proair HFA; Pravachol; Spiriva



Possible Evista side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-21

Patient: female

Reactions: Body Height Decreased, Femur Fracture, HIP Arthroplasty, Wrist Fracture, Knee Arthroplasty, Lower Limb Fracture

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Evista

Other drugs received by patient: Lovastatin; Calcium Carbonate; Vitamin D; Lecithin; Antacids, Other Combinations; Gabapentin; Meloxicam



Possible Evista side effects in 65 year old female

Reported by a physician from United States on 2012-03-12

Patient: 65 year old female

Reactions: Weight Decreased, Femur Fracture, Sciatica, Diverticulitis, Urinary Incontinence, Clostridium Difficile Colitis, Nocturia, Pyrexia, Fracture, Iron Deficiency Anaemia, Musculoskeletal Disorder, Tracheitis, Anaemia Postoperative, Pneumonia, Cerumen Impaction, Vulvovaginal Candidiasis, Type V Hyperlipidaemia, Bunion, Bone Pain, Adverse Drug Reaction, Fall, Constipation, Fatigue, Interstitial Lung Disease, Aortic Arteriosclerosis, Intervertebral Disc Degeneration, Sinusitis, Pharyngitis, Decreased Appetite, Vomiting, Mixed Incontinence, Diarrhoea, Pseudomembranous Colitis, Leukocytosis, Hypertension, Lung Infiltration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Alendronate Sodium
    Administration route: Oral

Evista
    Administration route: Oral
    Indication: Osteoporosis

Fosamax
    Administration route: Oral
    Indication: Osteopenia
    Start date: 1999-01-01
    End date: 2009-01-01

Fosamax
    Administration route: Oral

Fosamax
    Administration route: Oral
    End date: 2010-01-08

Fosamax
    Administration route: Oral
    End date: 2010-01-08

Fosamax
    Administration route: Oral

Fosamax
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 1999-01-01
    End date: 2009-01-01

Fosamax Plus D
    Administration route: Oral

Other drugs received by patient: Selective Estrogen Receptor Modulator (Unspecified); Lovaza; Viactiv Soft Calcium Chews; Vitamin D (Unspecified); Omega-3 Marine Triglycerides; Vitamin E; Vitamins (Unspecified); Citracal



Possible Evista side effects in 65 year old female

Reported by a physician from United States on 2012-01-25

Patient: 65 year old female

Reactions: Weight Decreased, Femur Fracture, Diverticulitis, Adverse Drug Reaction, Bone Pain, Sciatica, Nocturia, Pyrexia, Fall, Fatigue, Interstitial Lung Disease, Iron Deficiency Anaemia, Fracture, Aortic Arteriosclerosis, Intervertebral Disc Degeneration, Sinusitis, Tracheitis, Decreased Appetite, Pharyngitis, Vomiting, Pneumonia, Cerumen Impaction, Vulvovaginal Candidiasis, Mixed Incontinence, Diarrhoea, Type V Hyperlipidaemia, Pseudomembranous Colitis, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Alendronate Sodium
    Administration route: Oral

Evista
    Administration route: Oral
    Indication: Osteoporosis

Fosamax
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 1999-01-01
    End date: 2009-01-01

Fosamax
    Administration route: Oral
    End date: 2010-01-08

Fosamax
    Administration route: Oral

Fosamax
    Administration route: Oral
    End date: 2010-01-08

Fosamax
    Administration route: Oral

Fosamax
    Administration route: Oral
    Indication: Osteopenia
    Start date: 1999-01-01
    End date: 2009-01-01

Fosamax Plus D
    Administration route: Oral

Other drugs received by patient: Selective Estrogen Receptor Modulator (Unspecified); Viactiv Soft Calcium Chews; Vitamin D (Unspecified); Citracal; Omega-3 Marine Triglycerides; Vitamins (Unspecified); Lovaza; Vitamin E



Possible Evista side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-20

Patient: female

Reactions: Femur Fracture

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Actonel
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2003-11-03
    End date: 2006-04-20

Boniva
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2006-04-20

Evista
    Administration route: Oral
    Indication: Osteopenia
    Start date: 2003-11-03
    End date: 2003-11-03

Premarin
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Lyrica; Potassium Chloride; Metoprolol Tartrate; Lanoxin; Coumadin; Lasix



Possible Evista side effects in 47 year old female

Reported by a physician from United States on 2011-11-28

Patient: 47 year old female, weighing 57.0 kg (125.4 pounds)

Reactions: Femur Fracture, Breast Cancer in Situ, Fall, Chronic Obstructive Pulmonary Disease, Breast Cyst, Breast Hyperplasia, Injury, Fibula Fracture, Hypercalciuria, LOW Turnover Osteopathy, Mitral Valve Prolapse, Lung Neoplasm, Breast Mass, Granuloma, Ankle Fracture, Lung Disorder, Rhinitis Allergic, Bone Neoplasm Malignant, Procedural Vomiting, Procedural Nausea, Sleep Apnoea Syndrome, Face Injury

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Evista
    Indication: Bone Disorder
    Start date: 2008-01-01

Fosamax
    Administration route: Oral
    Start date: 2002-01-31
    End date: 2010-01-01

Fosamax
    Administration route: Oral
    Indication: Osteopenia
    Start date: 2000-10-01
    End date: 2001-12-01

Fosamax
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2000-10-01
    End date: 2001-12-01

Fosamax
    Administration route: Oral
    Start date: 2000-10-01
    End date: 2009-09-01

Fosamax
    Administration route: Oral
    Start date: 2000-10-01
    End date: 2009-09-01

Fosamax
    Administration route: Oral
    Start date: 2002-01-31
    End date: 2010-01-01

Other drugs received by patient: Vitamin D (Unspecified); Vitamins (Unspecified); Calcium (Unspecified)



Possible Evista side effects in 65 year old female

Reported by a physician from United States on 2011-11-14

Patient: 65 year old female

Reactions: Weight Decreased, Femur Fracture, Bone Pain, Diverticulitis, Adverse Drug Reaction, Sciatica, Nocturia, Pyrexia, Fall, Fatigue, Iron Deficiency Anaemia, Fracture, Intervertebral Disc Degeneration, Sinusitis, Tracheitis, Pharyngitis, Decreased Appetite, Vomiting, Cerumen Impaction, Vulvovaginal Candidiasis, Mixed Incontinence, Diarrhoea, Type V Hyperlipidaemia, Pseudomembranous Colitis, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Alendronate Sodium
    Administration route: Oral

Evista
    Administration route: Oral
    Indication: Osteoporosis

Fosamax
    Administration route: Oral
    End date: 2010-01-08

Fosamax
    Administration route: Oral
    Indication: Osteopenia
    Start date: 1999-01-01
    End date: 2009-01-01

Fosamax
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 1999-01-01
    End date: 2009-01-01

Fosamax
    Administration route: Oral
    End date: 2010-01-08

Fosamax
    Administration route: Oral

Fosamax
    Administration route: Oral

Fosamax Plus D
    Administration route: Oral

Other drugs received by patient: Lovaza; Vitamins (Unspecified); Citracal; Omega-3 Marine Triglycerides; Viactiv Soft Calcium Chews; Vitamin D (Unspecified); Vitamin E; Selective Estrogen Receptor Modulator (Unspecified)



Possible Evista side effects in female

Reported by a consumer/non-health professional from United States on 2011-10-17

Patient: female

Reactions: Contusion, Femur Fracture, Blood Calcium Increased, Blood Triglycerides Increased, Intentional Drug Misuse, Fall, Abdominal Discomfort, Malaise, Fatigue, Dizziness, Blood Cholesterol Increased, Vomiting, Nausea, Retching, Urinary Tract Infection, HIP Fracture, Heart Rate Increased, Swelling

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Evista
    Dosage: unk, unknown

Forteo
    Dosage: 20 ug, qd
    Indication: Osteoporosis
    Start date: 2011-04-04
    End date: 2011-04-05

Forteo
    Dosage: 20 ug, qd

Forteo
    Dosage: 20 ug, qd

Forteo
    Dosage: 20 ug, qd

Forteo
    Dosage: 20 ug, qd
    Start date: 2011-04-11

Other drugs received by patient: Cortisone Acetate



Possible Evista side effects in 92 year old female

Reported by a physician from United States on 2011-10-06

Patient: 92 year old female

Reactions: Vitamin D Deficiency, Vaginal Prolapse, Joint Instability, Femur Fracture, Flatulence, Chronic Obstructive Pulmonary Disease, Iron Deficiency Anaemia, Carotid Artery Occlusion, Ingrowing Nail, Sinus Congestion, LOW Turnover Osteopathy, Intervertebral Disc Protrusion, Dysphagia, Pneumonia, Drug Intolerance, Anaemia, Sinus Operation, Inguinal Hernia, Glaucoma, Pain, Myelodysplastic Syndrome, Cystocele, Fibrocystic Breast Disease, Road Traffic Accident, Overdose, Gastrooesophageal Reflux Disease, Blood Iron Increased, Tooth Fracture, Blood Urea Increased, Nephrogenic Anaemia, Blood Potassium Increased, Osteoarthritis, Carotid Artery Stenosis, Blood Pressure, Hypothyroidism

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Actonel
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2005-08-13
    End date: 2005-11-01

Actonel
    Administration route: Oral
    Start date: 2006-04-12
    End date: 2006-04-20

Actonel
    Administration route: Oral
    Start date: 2004-09-28
    End date: 2004-11-01

Alendronate Sodium
    Administration route: Oral
    Start date: 2008-08-02
    End date: 2009-03-13

Alendronate Sodium
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2008-06-07
    End date: 2008-08-01

Evista
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2005-10-27

Fosamax
    Administration route: Oral
    Start date: 2001-03-08

Fosamax
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2001-03-13
    End date: 2004-09-28

Fosamax
    Administration route: Oral
    Start date: 2005-07-13
    End date: 2010-01-11

Fosamax
    Administration route: Oral
    Start date: 1999-01-01
    End date: 2001-03-13

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017